Evaluation of dose-response curve analysis in delineating shared or different molecular sites of action for osteolathyrogens

Environmental Toxicology and Pharmacology

Volumn 16, Issue 1-2, 2004, Pages 13-23

  Dawson, Douglas A ^a   Scott, Brenda D ^a   Ellenberger, M Jason ^a   Pöch, Gerald ^b   Rinaldi, Andrea C ^c  

^a ASHLAND UNIVERSITY   (United States)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Dose response curves; Lysine tyrosylquinone; Lysyl oxidase; Mixture toxicity; Osteolathyrism; Xenopus

Indexed keywords

ACETONITRILE DERIVATIVE; METHYLENEAMINOACETONITRILE; SEMICARBAZIDE; THIOSEMICARBAZIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; EMBRYOTOXICITY; FROG; NEUROTOXICITY; NONHUMAN; NOTOCHORD; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TADPOLE; TOXICITY TESTING; ULTRAVIOLET SPECTROPHOTOMETRY;

ANURA;

EID: 1542346362     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2003.08.002     Document Type: Article

References (55)

1. Akagawa M., Suyama K. Characterization of a model compound for the lysine tyrosylquinone cofactor of lysyl oxidase. Biochem. Biophys. Res. Commun. 281:2001;193-199.
2. Bantle J.A., Burton D.T., Dawson D.A., Dumont J.N., Finch R.A., Fort D.J., Linder G., Rayburn J.R., Buchwalter D., Gaudet-Hull A.M., Maurice M.A., Turley S.D. FETAX interlaboratory validation study: phase II testing. Environ. Toxicol. Chem. 13:1994;1629-1637.
3. Biddle F.G. Use of dose-response relationships to discriminate between the mechanisms of cleft-palate induction by different teratogens: an argument for discussion. Teratology. 18:1978;247-252.
4. Bird T.A., Levene C.I. Lysyl oxidase (EC1.4.3.13): evidence that pyridoxal phosphate is a cofactor. Biochem. Biophys. Res. Commun. 108:1982;1172-1180.
5. Bliss C.I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26:1939;585-615.
6. Campaigne E. Thioketones. Patai S. The Chemistry of the Carbonyl Group. 1966;917-959 Interscience, London.
7. Cochran W.G. Some methods for strengthening the common chi-square tests. Biometrics. 10:1954;417-451.
8. Cotter M.A., Policz D.L., Pöch G., Dawson D.A. Analysis of the combined osteolathyritic effects of β-aminopropionitrile and diethyldithiocarbamate on Xenopus development. Toxicol. Sci. 58:2000;144-152.
9. Dasler W., Stoner R.G. Production of spinal curves in rats by chemically dissimilar substances. Experentia. 15:1959;112-115.
10. Dawson D.A., Bantle J.A. Development of a reconstituted water medium and preliminary validation of the Frog Embryo Teratogenesis Assay: Xenopus (FETAX). J. Appl. Toxicol. 7:1987;237-244.
11. Dawson D.A., Pöch G. A method for evaluating mechanistic aspects of chemical mixture toxicity. Toxicol. Methods. 7:1997;267-278.
12. Dawson, D.A., Pöch, G. (in press). Concentration-response curve slope analysis in chemical mixture toxicity. Arch. Complex Environ. Studies.
13. Dawson D.A., Fort D.J., Smith G.L., Newell D.A., Bantle J.A. Evaluation of the developmental toxicity of nicotine and cotinine with Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Terat. Carcin. Mut. 8:1988;329-338.
14. Dawson D.A., Schultz T.W., Baker L.L., Mannar A. Structure-activity relationships for osteolathyrism: III. Substituted thiosemicarbazides. J. Appl. Toxicol. 10:1990;59-64.
15. Dawson D.A., Schultz T.W., Baker L.L. Structure-activity relationships for osteolathyrism: IV. para-substituted benzoid acid hydrazides and alkyl carbazates. Environ. Toxicol. Chem. 10:1991;455-461.
16. Dawson D.A., Cotter M.A., Policz D.L., Stoffer D.A., Nichols J.P., Pöch G. Comparative evaluation of the combined osteolathyritic effects of two nitrile combinations on Xenopus embryos. Toxicology. 147:2000;193-207.
17. Dawson D.A., Rinaldi A.C., Pöch G. Biochemical and toxicological evaluation of agent-cofactor reactivity as a mechanism of action for osteolathyrism. Toxicology. 177:2002;267-284.
18. Deshmukh K., Nimni M.E. A defect in the intramolecular and intermolecular cross-linking of collagen caused by penicillamine. II. Functional groups involved in the interaction process. J. Biol. Chem. 244:1969;1787-1795.
19. Dunnett C.W. A multiple comparisons procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50:1955;1096-1121.
20. Fort D.J., Dawson D.A., Bantle J.A. Development of a metabolic activation system for the Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Terat. Carcin. Mut. 8:1988;251-263.
21. Harris E.D., Gonnerman W.A., Savage J.E., O'Dell B.L. Connective tissue amine oxidase II. Purification and partial characterization of lysyl oxidase from chick aorta. Biochim. Biophys. Acta. 341:1974;332-344.
22. Holzmann S., Dittrich P., Pöch G. Dose-response curves of vasorelaxants: computerized calculation of combination effects using the example of nicorandil. J. Clin. Basic Cardiol. 2:1999;96-98.
23. Kagan H.M. Characterization and regulation of LO. Mecham R.P. Biology of the Extracellular Matrix, Vol 1: Regulation of Matrix Accumulation. 1986;321-398 Academic Press, Orlando, FL.
24. Kagan H.M., Trackman P.C. Properties and function of lysyl oxidase. Am. J. Respir. Cell Mol. Biol. 5:1991;206-210.
25. Kagan H.M., Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell Biochem. 88:2003;660-672.
26. Lee Y., Ling K.-Q., Lu X., Silverman R.B., Shepard E.M., Dooley D.M., Sayre L.M. 3-Pyrrolines are mechanism-based inactivators of the quinone-dependent amine oxidases but only substrates of the flavin-dependent amine oxidases. J. Am. Chem. Soc. 124:2002;12135-12143.
27. Levene C.I. Effects of lathyrogenic compounds on the cross-linking of collagen and elastin in vivo. Aldridge W.N. Mechanisms of Toxicity. 1971;67-85 St. Martin's Press, New York.
28. Levene C.I. Lathyrism. Perez-Tamayo R., Rojkink M. Molecular Pathology of Connective Tissues. 1973;175-220 Marcel Dekker, New York.
29. Ling K.-Q., Kim J., Sayre L.M. Catalytic turnover of benzylamine by a model for the lysine tyrosylquinone (LTQ) cofactor of lysyl oxidase. J. Am. Chem. Soc. 123:2001;9606-9611.
30. Liu G., Kaliappanadar N., Kagan H.M. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. J. Biol. Chem. 272:1997;32370-32377.
31. Nagan N., Callery P.S., Kagan H.M. Aminoalkylaziridines as substrates and inhibitors of lysyl oxidase: specific inactivation of the enzyme by N-(5-aminopentyl)aziridine. Front. Biosci. 3:1998;a23-26.
32. Nau H. Toxikokinetik. Marquardt H., Schäfer S.G. Lehrbich der Toxikologie. 1994;32-67 Bl-Wiss.-Verl, Mannheim, Germany.
33. Nieuwkoop P.D., Faber J. Normal Table of Xenopus laevis (Daudin). 1994;Garland, New York. 252 pp.
34. Pinnell S.R., Martin G.R. The cross-linking of collagen and elastin: enzymatic conversion of lysine in peptide linkage to α-aminoadipic- δ-semialdehyde (allysine) by an extract from bone. Proc. Natl. Acad. Sci. USA. 61:1968;708-714.
35. Pöch G. Combined Effects of Drugs and Toxic Agents: Modern Evaluation in Theory and Practice. 1993;Springer-Verlag, Vienna. 167 pp.
36. Pöch, G., Dawson, D.A. (submitted). Dose-response curves of toxic agents, singly and in combination. Environ. Toxicol. Pharmacol.
37. Pöch G., Dittrich P., Holzmann S. Evaluation of combination effects in dose-response studies by statistical comparison with additive and independent interactions. J. Pharmacol. Methods. 24:1990;311-325.
38. Pöch G., Dawson D.A., Reiffenstein R.J. Model usage in evaluation of combined effects of toxicants. Toxicol. Ecotoxicol. News. 3:1996;51-59.
39. Pöch G., Dawson D.A., Dittrich P. Teratogenic mixtures: analysis of experimental dose-response curves and statistical comparison with theoretical effects. Arch. Complex. Environ. Stud. 9:1997;23-33.
40. Riggin G.W., Schultz T.W. Teratogenic effects of benzoyl hydrazine on frog embryos. Trans. Am. Microsc. Soc. 105:1986;197-210.
41. Rinaldi A.C., Rescigno A., Rinaldi A., Sanjust E. Modeling novel quinocofactors: an overview. Bioorg. Chem. 27:1999;253-288.
42. Roscoe J.T., Byars J.A. Sample size restraints commonly imposed on the use of the chi-square statistic. J. Am. Stat. Assoc. 66:1971;755-759.
43. Sarma P.S., Padmanaban G. Lathyrogens. Liener I.E. Toxic Constituents of Plant Foodstuffs. 1969;267-291 Academic Press, New York.
44. Schultz T.W., Ranney T.S. Structure-activity relationships for osteolathyrism: II. effects of alkyl-substituted acid hydrazides. Toxicology. 53:1988;147-159.
45. Schultz T.W., Dumont J.N., Epler R.G. The embryotoxic and teratogenic effects of semicarbazide. Toxicology. 36:1985;183-198.
46. Schultz T.W., Ranney T.S., Riggin G.W., Cajina-Quezada M. Structure-activity relationships for osteolathyrism: I. effects of altering the semicarbazide structure. Trans. Am. Microsc. Soc. 107:1988;113-126.
47. Selye H. Lathyrism. Rev. Can. Biol. 16:1957;1-82.
48. Shepard E.M., Smith J., Elmore B.O., Kuchar J.A., Sayre L.M., Dooley D.M. Towards the development of selective amine oxidase inhibitors. Mechanism-based inhibition of six copper containing amine oxidases. Eur. J. Biochem. 269:2002;3645-3658.
49. Smith-Mungo L.I., Kagan H.M. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 16:1998;387-398.
50. Steel R.G.D., Torrie J.H. Principles and Procedures of Statistics: a Biometrical Approach. second ed:1980;McGraw-Hill, New York. 633 pp.
51. Tang C., Klinman J.P. The catalytic function of bovine lysyl oxidase in the absence of copper. J. Biol. Chem. 276:2001;30575-30578.
52. Tang S.S., Trackman P.C., Kagan H.M. Reaction of aortic lysyl oxidase with β-aminopropionitrile. J. Biol. Chem. 258:1983;4331-4338.
53. Wang S.X., Mure M., Medzihradszky K.F., Burlingame A.L., Brown D.E., Dooley D.M., Smith A.J., Kagan H.M., Klinman J.P. A cross-linked cofactor in LO: redox function for amino side chains. Science. 273:1996;1078-1084.
54. Wang S.X., Nakamura N., Mure M., Klinman J.P., Sanders-Loehr J. Characterization of the native lysine tyrosylquinone cofactor in lysyl oxidase by Raman spectroscopy. J. Biol. Chem. 272:1997;28841-28844.
55. Zar J.H. Biostatistical Analysis. second ed:1984;Prentice-Hall, Englewood Cliffs, NJ.